Epoch Investment Partners Inc. Cuts Stock Position in HCA Healthcare, Inc. $HCA

Epoch Investment Partners Inc. reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 12.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 412,897 shares of the company’s stock after selling 59,842 shares during the period. HCA Healthcare makes up 1.2% of Epoch Investment Partners Inc.’s portfolio, making the stock its 11th biggest position. Epoch Investment Partners Inc. owned approximately 0.19% of HCA Healthcare worth $195,399,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Palisade Asset Management LLC bought a new stake in HCA Healthcare during the 3rd quarter valued at about $26,000. Ares Financial Consulting LLC bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $31,000. Cedar Mountain Advisors LLC purchased a new stake in HCA Healthcare during the 1st quarter valued at $33,000. JPL Wealth Management LLC purchased a new stake in shares of HCA Healthcare during the third quarter valued at $33,000. Finally, MCF Advisors LLC lifted its stake in HCA Healthcare by 213.0% during the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock valued at $34,000 after acquiring an additional 49 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

HCA opened at $382.28 on Friday. The stock has a market capitalization of $84.80 billion, a price-to-earnings ratio of 13.15, a PEG ratio of 1.27 and a beta of 1.12. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The company has a fifty day moving average of $386.95 and a 200 day moving average of $453.73.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. During the same quarter last year, the business posted $6.84 earnings per share. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 29.19 earnings per share for the current year.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA beat Q2 earnings estimates, reporting $7.59 per share versus expectations around $7.56-$7.57, while revenue rose 8.7% year over year to $20.23 billion and also topped estimates. HCA Healthcare earnings report
• Positive Sentiment: Management cited strong admissions and higher revenue per admission as key drivers of the quarter, suggesting healthy demand trends across its hospital network. Zacks article on HCA Q2 results
• Neutral Sentiment: HCA said its updated guidance is consistent with its earlier preview, so the quarter appears to confirm previously signaled results rather than deliver a major surprise. BusinessWire Q2 results
• Negative Sentiment: The company trimmed parts of its 2026 outlook, pointing to higher expenses and weaker surgical volumes as headwinds that could limit margin expansion. Zacks guidance revision article
• Negative Sentiment: Separate investor-law-firm investigations into HCA may add some legal overhang, though these notices are not operational results. Pomerantz investor alert

Analyst Ratings Changes

HCA has been the subject of a number of research analyst reports. JPMorgan Chase & Co. cut their target price on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research report on Tuesday, May 19th. Weiss Ratings downgraded HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Raymond James Financial set a $528.00 target price on shares of HCA Healthcare in a report on Tuesday, July 7th. TD Cowen decreased their target price on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Finally, Cantor Fitzgerald reduced their price target on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research report on Tuesday, July 7th. Fourteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $483.45.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.